Evidence map›Paper›PMID 41376686›Full record

ArticlePublic health action2025

Development of a history-taking form for mesothelioma patients at risk of exposure to asbestos.

R Singh, R Kumar, M Nagar, S B Kaipilyawar, H A Anderson, A V Jadhav, T Patel, T R Drischoll, E Prriya, S R Yadav and 17 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Public health action, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

R SinghDepartment of Environmental and Occupational Health, Dornsife School of Public Health, Drexel University, Philadelphia, PA, USA.
R KumarDepartment of Pulmonary Medicine, Critical Care Medicine and Sleep Disorders, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India.
M NagarDepartment of Medical Oncology, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India.
S B KaipilyawarPublic Health, Society for Health Allied Research & Education, Hyderabad, India.
H A AndersonDepartment of Population Health Sciences, School of Medicine and Public Health, University of Wisconsin, Madison, USA.
A V JadhavDepartment of Epidemiology, ICMR-National Institute of Virology, Pune, India.
T PatelDepartment of Pathology, All India Institute of Medical Sciences, Rajkot, India.
T R DrischollSydney School of Public Health, The University of Sydney, Sydney, Australia.
E PrriyaThoracic Surgery, Navi Mumbai, India.
S R YadavDepartment of Pulmonary Medicine, Vallabhbhai Patel Chest Institute, University of Delhi, New Delhi, India.
S BishnoiThoracic Surgery, Medanta Hospital, Gurugram, India.
N SinghDepartment of Pulmonary Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
K KaurDepartment of Pathology, Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India.
A JakhetiyaDepartment of Surgical Oncology, Geetanjali Medical College, Udaipur, India.
N van ZandwijkDepartment of Cell and Molecular Therapies, Royal Prince Alfred Hospital, Sydney Local District & University of Sydney, Sydney, Australia.
S KumariGynae-Surgical Oncology, Max Hospital, New Delhi, India.
D KhoslaDepartment of Radiotherapy and Oncology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
S RajanDepartment of Surgical Oncology, King George's Medical University, Lucknow, India.
A K VermaDepartment of Respiratory Medicine, King George's Medical University, Lucknow, India.
A BhattDepartment of Surgical Oncology, Shalby Cancer and Research Institute, Ahmedabad, India.
A SharmaDepartment of Medical Oncology, National Cancer Institute, Jhajjar, (All India Institute of Medical Sciences, New Delhi), India.
D K SinhaDepartment of Radiation Oncology, Indira Gandhi Institute of Medical Sciences, Patna, India.
A KapoorDepartment of Medical Oncology, Mahamana Pandit Madan Mohan Malaviya Cancer Centre & Homi Bhabha Cancer Hospital, Tata Memorial Centre, Varanasi, India.
R GillDepartment of Radiology, Columbia University, New York, USA.
R DadaLaboratory for Molecular Reproduction and Genetics, Department of Anatomy, All India Institute of Medical Sciences, New Delhi, India.
J KishoreDepartment of Community Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India.
A L FrankDepartment of Environmental and Occupational Health, Dornsife School of Public Health, Drexel University, Philadelphia, PA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMesothelioma is causally established to be primarily related to asbestos exposure as a risk factor. Before considering other possible causative factors for mesothelioma, a detailed exposure history is warranted, which looks at possible prior exposures to asbestos. Some exposures may be unknown to patients, may be forgotten or may not be readily available as a comprehensive tool for the clinicians dealing with mesothelioma patients.

methodsWe used the Delphi anonymous consensus technique to develop and validate a detailed, seven-sectioned, and comprehensive questionnaire that can be readily used by clinicians and researchers. Over two rounds, the experts followed a thorough and rigorous process to validate the questionnaire, including medical history along with occupational, non-occupational as well as para-occupational exposure to asbestos, and many other parameters that can be both rule in and rule out the possibility of mesothelioma. Questions have also been included to factor in other types of dust exposure for an informed differential diagnosis.

resultsWe have created a readily available history-taking questionnaire validated by experts, which can be replicated for other conditions and become an essential tool for diagnosis.

conclusionApart from accurate and informed diagnosis, this documentation can be valuable for epidemiological, research, policy-informing, legal and compensation related issues.

Indexed as

asbestos exposuredifferential diagnosismarbleoccupational healthperitoneal mesotheliomapleural mesotheliomastone-cutting

Identifiers

PMID41376686
PMCPMC12687119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.